The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 22, 2025
Filed:
Jul. 21, 2023
Applicant:
Abionyx Pharma SA, Balma, FR;
Inventors:
Jean-Louis Dasseux, Toulouse, FR;
Laura Calabresi, Milan, IT;
Cyrille Tupin, Castelmaurou, FR;
Ronald Barbaras, Seilh, FR;
Constance Peyrottes, Le Castera, FR;
Assignee:
ABIONYX PHARMA SA, Balma, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 31/688 (2006.01); A61K 45/06 (2006.01); A61K 47/24 (2006.01); A61P 13/12 (2006.01); C07K 14/775 (2006.01);
U.S. Cl.
CPC ...
A61K 31/688 (2013.01); A61K 47/24 (2013.01); C07K 14/775 (2013.01); A61K 38/00 (2013.01);
Abstract
Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG) for treating kidney diseases, and methods for treating a subject having kidney diseases with CER-001. For example, the kidney disease can be associated with a lecithin cholesterol acyl transferase (LCAT) deficiency.